Fresenius Kabi Canada Ltd.
Fresenius Kabi Canada Ltd., a subsidiary of the global healthcare group Fresenius Kabi, is headquartered in Canada and operates extensively across the country. Founded in 1999, the company has established itself as a key player in the pharmaceutical and medical device industry, focusing on lifesaving medicines and technologies. Fresenius Kabi is renowned for its comprehensive portfolio, which includes intravenous (IV) drugs, infusion therapies, and clinical nutrition products. These offerings are distinguished by their commitment to quality and innovation, ensuring optimal patient care. With a strong market position, Fresenius Kabi Canada has achieved notable milestones, including advancements in biosimilars and a robust supply chain that supports healthcare providers nationwide.
DitchCarbon Score
How does Fresenius Kabi Canada Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fresenius Kabi Canada Ltd.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fresenius Kabi Canada Ltd. currently does not have available carbon emissions data, as indicated by the absence of specific figures for kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Fresenius Kabi Canada Ltd. may not have publicly committed to specific climate initiatives or emissions reduction strategies at this time. In the context of the pharmaceutical and healthcare industry, companies are increasingly focusing on sustainability and carbon footprint reduction. However, without specific commitments or data, it is unclear how Fresenius Kabi Canada Ltd. aligns with these industry trends. As the company continues to operate, it may consider establishing measurable targets and reporting frameworks to enhance its climate commitments and transparency in emissions management.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 521,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 1,013,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fresenius Kabi Canada Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
